Ozempic Changed Everything: How GLP-1 Drugs Are Reshaping Obesity, Health And Stigma

Ozempic arrived and suddenly the conversation around obesity changed.New medications known as GLP-1 receptor agonists are transforming how many people think about weight, health and obesity. But they are also raising difficult questions about access, stigma, personal responsibility and the role of public health systems.In this episode of Change My Mind, Lynda Steele sits down with Dr. Ali Zentner, a British Columbia–based physician and advocate for evidence-based obesity care, to explore what the rise of obesity medications reveals about how society understands obesity itself.Together, they examine whether these medications are changing the definition of obesity as a medical condition, how they fit into broader conversations about body positivity and weight stigma, while also exploring why access to treatment remains deeply unequal.The discussion moves beyond the question of whether these drugs are "good" or "bad" and instead explores what happens when a new medical treatment challenges long-held beliefs about health, choice and responsibility.As always, the goal isn't to win an argument. It's to think differently.No debate. No winning. Just talking it through.